Women Home > Precautions and Warnings With Sibutramine

Precautions and warnings with sibutramine should be reviewed with your healthcare provider prior to beginning treatment. This includes telling him or her if you have a history of heart problems, liver or kidney disease, or glaucoma. You should also be aware of potential side effects of sibutramine and how they may be avoided. Precautions and warnings with sibutramine also extend to people with certain allergies and women who are pregnant or breastfeeding.

Sibutramine: What Should I Tell My Healthcare Provider?

In October 2010, sibutramine hydrochloride was withdrawn from the market in the United States. Studies have shown that it increases the risk of heart attacks and strokes. This medication will no longer be available in the United States. People should stop taking it and should ask their healthcare providers about more appropriate weight loss options. 
You should talk with your healthcare provider prior to taking sibutramine hydrochloride monohydrate (Meridia®) if you have:
Also, let your healthcare provider know if you are:
  • Pregnant or thinking of becoming pregnant
  • Breastfeeding.
You should also be sure to tell your healthcare provider about any other medicines you are taking, including prescription and non-prescription medicines, vitamins, and herbal supplements.
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation




Related Channels

eMedTV Links
Copyright © 2006-2020 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.